Table 3. Investigation of putative upstream regulators.
Differentially expressed transcripts in differentiated Schwann cells were analyzed in respect to their potential upstream regulators.
Upstream regulator | Common name | Predicted activation state | Activation z-score | P-value of overlap |
---|---|---|---|---|
Forskolin | Activated | 2.508 | 3.90×10−15 | |
CHUK | Inhibitor of nuclear factor kappa-B kinase subunit α | Activated | 2.387 | 4.83×10−15 |
IKBKG | Inhibitor of kappaB kinase subunit γ | Activated | 2.982 | 1.61×10−13 |
IKBKB | Inhibitor of kappaB kinase subunit β | Activated | 2.985 | 1.21×10−10 |
STAT3 | Signal transducer and activator of transcription 3 | Activated | 2.462 | 8.81×10−7 |
CEBPB | C/EBP-beta, NF-IL6 | Activated | 2.201 | 5.81×10−6 |
SOX10 | SRY-box containing gene 10 | Activated | 2.200 | 1.57×10−5 |
HOXC8 | Homeobox C8 | Activated | 2.000 | 6.41×10−3 |
Tnf (family) | Tumor necrosis factor | Activated | 2.132 | 9.84×10−3 |
HOXC6 | Homeobox C6 | Activated | 2.000 | 1.51×10−2 |
ZNF217 | Zinc finger protein 217 | Activated | 2.236 | 3.36×10−2 |
PTPRJ | Protein tyrosine phosphatase, receptor type, J | Activated | 2.000 | 4.33×10−2 |
NOTCH1 | Notch1 | Inhibited | −2.318 | 8.05×10−6 |
SRF | Serum response factor | Inhibited | −2.668 | 1.12×10−5 |
TGFB3 | Transforming growth factor, β 3 | Inhibited | −2.559 | 3.31×10−5 |
KLF4 | Kruppel-like factor 4 | Inhibited | −2.599 | 5.93×10−4 |
Nfat (family) | Nuclear factor of activated T cells | Inhibited | −2.121 | 6.60×10−4 |
LYN | Yamaguchi sarcoma viral (v-yes-1) oncogene homolog | Inhibited | −2.186 | 4.21×10−3 |
RAC1 | RAS-related C3 botulinum substrate 1 | Inhibited | −2.173 | 5.11×10−3 |
MAP2K1/2 | Mek1/2 | Inhibited | −2.177 | 9.43×10−3 |
MKL1 | MKL (megakaryoblastic leukemia)/myocardin-like 1 | Inhibited | −2.160 | 1.26×10−2 |
SFTPA1 | Surfactant associated protein A1 | Inhibited | −2.200 | 3.19×10−2 |
IKZF1 | IKAROS family zinc finger 1 | Inhibited | −2.433 | 3.92×10−2 |